Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Vonderheide, RH; Dutcher, JP; Anderson, JE; Eckhardt, SG; Caron, DA; Gribben, JG
   Cd40 ligand therapy of lymphoma patients - Reply
   JOURNAL OF CLINICAL ONCOLOGY
   
   R.H. Vonderheide et al., "Cd40 ligand therapy of lymphoma patients - Reply", J CL ONCOL, 19(23), 2001, pp. 4352-4353
2. Vonderheide, RH; Dutcher, JP; Anderson, JE; Eckhardt, SG; Stephans, KF; Razvillas, B; Garl, S; Butine, MD; Perry, VP; Armitage, RJ; Ghalie, R; Caron, DA; Gribben, JG
   Phase I study of recombinant human CD40 ligand in cancer patients
   JOURNAL OF CLINICAL ONCOLOGY
   
   R.H. Vonderheide et al., "Phase I study of recombinant human CD40 ligand in cancer patients", J CL ONCOL, 19(13), 2001, pp. 3280-3287
3. Dutcher, JP
   Intravenous allopurinol in the prevention and treatment of tumor lysis syndrome - Introduction
   SEMINARS IN ONCOLOGY
   
   J.P. Dutcher, "Intravenous allopurinol in the prevention and treatment of tumor lysis syndrome - Introduction", SEMIN ONCOL, 28(2), 2001, pp. 1-2
4. Unnikrishnan, D; Dutcher, JP; Varshneya, N; Lucariello, R; Wiernik, PH; Chiaramida, S
   Response: Monitoring of cardiac toxicity with arsenic trioxide
   BLOOD
   
   D. Unnikrishnan et al., "Response: Monitoring of cardiac toxicity with arsenic trioxide", BLOOD, 98(5), 2001, pp. 1633-1634
5. Unnikrishnan, D; Dutcher, JP; Varshneya, N; Lucariello, R; Api, M; Garl, S; Wiernik, PH; Chiaramida, S
   Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide
   BLOOD
   
   D. Unnikrishnan et al., "Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide", BLOOD, 97(5), 2001, pp. 1514-1516
6. Dutcher, JP; Logan, T; Gordon, M; Sosman, J; Weiss, G; Margolin, K; Plasse, T; Mier, J; Lotze, M; Clark, J; Atkins, M
   Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: A Cytokine Working Group study
   CLINICAL CANCER RESEARCH
   
   J.P. Dutcher et al., "Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: A Cytokine Working Group study", CLIN CANC R, 6(9), 2000, pp. 3442-3450
7. Dutcher, JP; Novik, Y; O'Boyle, K; Marcoullis, G; Secco, C; Wiernik, PH
   20th-century advances in drug therapy in oncology - Part I
   JOURNAL OF CLINICAL PHARMACOLOGY
   
   J.P. Dutcher et al., "20th-century advances in drug therapy in oncology - Part I", J CLIN PHAR, 40(9), 2000, pp. 1007-1024
8. Dutcher, JP; Novik, Y; O'Boyle, K; Marcoullis, G; Secco, C; Wiernik, PH
   20th-century advances in drug therapy in oncology - Part II
   JOURNAL OF CLINICAL PHARMACOLOGY
   
   J.P. Dutcher et al., "20th-century advances in drug therapy in oncology - Part II", J CLIN PHAR, 40(10), 2000, pp. 1079-1092
9. Novik, Y; Ryan, LM; Haller, DG; Asbury, R; Dutcher, JP; Schutt, A
   Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282
   MEDICAL ONCOLOGY
   
   Y. Novik et al., "Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282", MED ONCOL, 16(4), 1999, pp. 261-266
10. Deshpande, H; Dutcher, JP; Novik, Y; Oleksowicz, L
    Successful treatment of a patient on adrenal steroid replacement therapy high-dose bolus interleukin-2 for metastatic renal cell carcinoma
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    
    H. Deshpande et al., "Successful treatment of a patient on adrenal steroid replacement therapy high-dose bolus interleukin-2 for metastatic renal cell carcinoma", CA J SCI AM, 5(1), 1999, pp. 52-53
11. Atkins, MB; Lotze, MT; Dutcher, JP; Fisher, RI; Weiss, G; Margolin, K; Abrams, J; Sznol, M; Parkinson, D; Hawkins, M; Paradise, C; Kunkel, L; Rosenberg, SA
    High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993
    JOURNAL OF CLINICAL ONCOLOGY
    
    M.B. Atkins et al., "High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993", J CL ONCOL, 17(7), 1999, pp. 2105-2116
12. Oleksowicz, L; Dutcher, JP
    A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinoma
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    L. Oleksowicz e J.P. Dutcher, "A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinoma", J CANC RES, 125(2), 1999, pp. 101-108
13. Dutcher, JP; Wiernik, PH
    Novel biologic approaches to hematologic malignancies
    DIAGNOSTIC AND THERAPEUTIC ADVANCES IN HEMATOLOGIC MALIGNANCIES
    
    J.P. Dutcher e P.H. Wiernik, "Novel biologic approaches to hematologic malignancies", CANC TREAT, 99, 1999, pp. 275-306
14. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
    Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon
    MEDICAL ONCOLOGY
    
    R.K. Alpaugh et al., "Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon", MED ONCOL, 15(3), 1998, pp. 191-198
15. Wu, JJ; Caliendo, G; Hu, XP; Dutcher, JP
    Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma
    MEDICAL ONCOLOGY
    
    J.J. Wu et al., "Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma", MED ONCOL, 15(1), 1998, pp. 44-49
16. BHAGWATI N; SENO R; DUTCHER JP; OLEKSOWICZ L
    FULMINANT METASTATIC MELANOMA COMPLICATED BY A MICROANGIOPATHIC HEMOLYTIC-ANEMIA
    Hematopathology and molecular hematology
    
    N. Bhagwati et al., "FULMINANT METASTATIC MELANOMA COMPLICATED BY A MICROANGIOPATHIC HEMOLYTIC-ANEMIA", Hematopathology and molecular hematology, 11(2), 1998, pp. 101-108
17. WIERNIK PH; DUTCHER JP; EINZIG AI; SPARANO J; FRANK M; FRIEDENBERG W
    MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE
    The cancer journal from Scientific American
    
    P.H. Wiernik et al., "MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE", The cancer journal from Scientific American, 4(4), 1998, pp. 254-260
18. WADLER S; ATKINS M; KARP D; NEUBERG D; HAYNES H; DUTCHER JP
    CLINICAL-TRIAL OF WEEKLY INTENSIVE THERAPY WITH 5-FLUOROURACIL ON 2 DIFFERENT SCHEDULES COMBINED WITH INTERFERON ALPHA-2A AND FILGRASTIM INPATIENTS WITH ADVANCED SOLID TUMORS - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY P-Z991
    The cancer journal from Scientific American
    
    S. Wadler et al., "CLINICAL-TRIAL OF WEEKLY INTENSIVE THERAPY WITH 5-FLUOROURACIL ON 2 DIFFERENT SCHEDULES COMBINED WITH INTERFERON ALPHA-2A AND FILGRASTIM INPATIENTS WITH ADVANCED SOLID TUMORS - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY P-Z991", The cancer journal from Scientific American, 4(4), 1998, pp. 261-268
19. MROWIEC ZR; OLEKSOWICZ L; DELEONFERNANDEZ M; LALEZARI P; DUTCHER JP; PUSZKIN EG
    APYRASE, ASCORBIC-ACID AND APROTININ AMELIORATE THE STORAGE LESION INPELLETED PLATELET PREPARATIONS (VOL 72, PG 259, 1997)
    Biotechnic & histochemistry
    
    Z.R. Mrowiec et al., "APYRASE, ASCORBIC-ACID AND APROTININ AMELIORATE THE STORAGE LESION INPELLETED PLATELET PREPARATIONS (VOL 72, PG 259, 1997)", Biotechnic & histochemistry, 73(5), 1998, pp. 6-6
20. DUTCHER JP; LEE S; PAIETTA E; BENNETT JM; STEWART JA; WIERNIK PH
    PHASE-II STUDY OF CARBOPLATIN IN BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY E1992
    Leukemia
    
    J.P. Dutcher et al., "PHASE-II STUDY OF CARBOPLATIN IN BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY E1992", Leukemia, 12(7), 1998, pp. 1037-1040
21. MALIK U; DUTCHER JP; OLEKSOWICZ L
    ACQUIRED GLANZMANNS-THROMBASTHENIA ASSOCIATED WITH HODGKINS LYMPHOMA - A CASE-REPORT AND REVIEW OF THE LITERATURE
    Cancer
    
    U. Malik et al., "ACQUIRED GLANZMANNS-THROMBASTHENIA ASSOCIATED WITH HODGKINS LYMPHOMA - A CASE-REPORT AND REVIEW OF THE LITERATURE", Cancer, 82(9), 1998, pp. 1764-1768
22. WHEATLEY D; DUTCHER JP; WIERNIK PH; HUGUET F; POLIN V; REIFFERS J; SOTTO JJ; STOPPA AM; MANDELLI F; PETTI MC; HAROUSSEAU JL; MERCIER M; POLIN V; TELLIER Z; BERMAN E; STAGG M; VOGLER WR; BEZWODA WR; ALISON R; CLARKE M; EVANS V; GRAY R; GREAVES E; HALL E; HICKS C; JAMES S; PETO R; RICHARDS S; SINCLAIR D; TOOTH A; WHEATLEY K
    A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA
    British Journal of Haematology
    
    D. Wheatley et al., "A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA", British Journal of Haematology, 103(1), 1998, pp. 100-109
23. WIERNIK PH; GALLAGHER RE; KIM S; PAIETTA E; DUTCHER JP
    PILOT-STUDY OF ARSENIC TRIOXIDE (ATO) IN ACUTE MYELOID-LEUKEMIA
    British Journal of Haematology
    
    P.H. Wiernik et al., "PILOT-STUDY OF ARSENIC TRIOXIDE (ATO) IN ACUTE MYELOID-LEUKEMIA", British Journal of Haematology, 102(1), 1998, pp. 329-329
24. MALIK UR; DUTCHER JP; CALIENDO G; LASALA P; MITNICK R; WIERNIK PH
    PHASE-II TRIAL OF MERBARONE IN PATIENTS WITH MALIGNANT BRAIN-TUMORS
    Medical oncology
    
    U.R. Malik et al., "PHASE-II TRIAL OF MERBARONE IN PATIENTS WITH MALIGNANT BRAIN-TUMORS", Medical oncology, 14(3-4), 1997, pp. 159-162
25. DUTCHER JP; FISHER RI; WEISS G; ARONSON F; MARGOLIN K; LOUIE A; MIER J; CALIENDO G; SOSMAN JA; ECKARDT JR; ERNEST M; DOROSHOW J; ATKINS M
    OUTPATIENT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA FOR METASTATIC RENAL-CELL CANCER - 5-YEAR FOLLOW-UP OF THE CYTOKINE WORKING GROUP-STUDY
    The cancer journal from Scientific American
    
    J.P. Dutcher et al., "OUTPATIENT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA FOR METASTATIC RENAL-CELL CANCER - 5-YEAR FOLLOW-UP OF THE CYTOKINE WORKING GROUP-STUDY", The cancer journal from Scientific American, 3(3), 1997, pp. 157-162
26. DUTCHER JP; ATKINS M; FISHER R; WEISS G; MARGOLIN K; ARONSON F; SOSMAN J; LOTZE M; GORDON M; LOGAN T; MIER J
    INTERLEUKIN-2-BASED THERAPY FOR METASTATIC RENAL-CELL CANCER - THE CYTOKINE WORKING GROUP EXPERIENCE, 1989-1997
    The cancer journal from Scientific American
    
    J.P. Dutcher et al., "INTERLEUKIN-2-BASED THERAPY FOR METASTATIC RENAL-CELL CANCER - THE CYTOKINE WORKING GROUP EXPERIENCE, 1989-1997", The cancer journal from Scientific American, 3, 1997, pp. 73-78
27. SOSMAN JA; ARONSON FR; SZNOL M; ATKINS MB; DUTCHER JP; WEISS GR; ISAACS RE; MARGOLIN KA; FISHER RI; ERNEST ML; MIER J; OLEKSOWICZ L; ECKHARDT JR; LEVITT D; DOROSHOW JH
    CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY
    Clinical cancer research
    
    J.A. Sosman et al., "CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY", Clinical cancer research, 3(1), 1997, pp. 39-46
28. MROWIEC ZR; OLEKSOWICZ L; DELEONFERNANDEZ M; PUSZKIN EG; DUTCHER JP
    APYRASE, ASCORBIC-ACID AND APROTININ AMELIORATE THE STORAGE LESION INPELLETED PLATELET PREPARATIONS
    Biotechnic & histochemistry
    
    Z.R. Mrowiec et al., "APYRASE, ASCORBIC-ACID AND APROTININ AMELIORATE THE STORAGE LESION INPELLETED PLATELET PREPARATIONS", Biotechnic & histochemistry, 72(5), 1997, pp. 259-267
29. LEAF AN; NEUBERG D; SCHWARTZ EL; WADLER S; RITCH PS; DUTCHER JP; ADAMS GL
    AN ECOG PHASE-II STUDY OF AMONAFIDE IN UNRESECTABLE OR RECURRENT CARCINOMA OF THE HEAD AND NECK (PB390)
    Investigational new drugs
    
    A.N. Leaf et al., "AN ECOG PHASE-II STUDY OF AMONAFIDE IN UNRESECTABLE OR RECURRENT CARCINOMA OF THE HEAD AND NECK (PB390)", Investigational new drugs, 15(2), 1997, pp. 165-172
30. DUTCHER JP; COLETTI D; PAIETTA E; WIERNIK PH
    A PILOT-STUDY OF ALPHA-INTERFERON AND PLICAMYCIN FOR ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA
    Leukemia research
    
    J.P. Dutcher et al., "A PILOT-STUDY OF ALPHA-INTERFERON AND PLICAMYCIN FOR ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA", Leukemia research, 21(5), 1997, pp. 375-380
31. DUTCHER JP; VENKATRAJ U; MAKOWER D; WIERNIK PH
    INTERLEUKIN-4 IS A PLEOTROPIC CYTOKINE WITH EFFECTS ON B-CELL MALIGNANCIES
    Leukemia research
    
    J.P. Dutcher et al., "INTERLEUKIN-4 IS A PLEOTROPIC CYTOKINE WITH EFFECTS ON B-CELL MALIGNANCIES", Leukemia research, 21(1), 1997, pp. 17-19
32. ATKINS MB; DUTCHER JP
    RENAL-CELL CARCINOMA
    The New England journal of medicine
    
    M.B. Atkins e J.P. Dutcher, "RENAL-CELL CARCINOMA", The New England journal of medicine, 336(11), 1997, pp. 809-809
33. OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; PAIETTA E; ETKIND P
    HUMAN BREAST-CARCINOMA CELLS SYNTHESIZE A PROTEIN IMMUNORELATED TO PLATELET GLYCOPROTEIN-IB-ALPHA WITH DIFFERENT FUNCTIONAL-PROPERTIES
    The Journal of laboratory and clinical medicine
    
    L. Oleksowicz et al., "HUMAN BREAST-CARCINOMA CELLS SYNTHESIZE A PROTEIN IMMUNORELATED TO PLATELET GLYCOPROTEIN-IB-ALPHA WITH DIFFERENT FUNCTIONAL-PROPERTIES", The Journal of laboratory and clinical medicine, 129(3), 1997, pp. 337-346
34. OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; ETKIND P
    A GPIB-ALPHA-RELATED PROTEIN IS EXPRESSED BY FRESH HUMAN BREAST-CARCINOMA TISSUE AND IS REGULATED BY A PKC-SENSITIVE MECHANISM
    Experimental cell research
    
    L. Oleksowicz et al., "A GPIB-ALPHA-RELATED PROTEIN IS EXPRESSED BY FRESH HUMAN BREAST-CARCINOMA TISSUE AND IS REGULATED BY A PKC-SENSITIVE MECHANISM", Experimental cell research, 237(1), 1997, pp. 110-117
35. OBOYLE KP; WANG YX; SCHWARTZ EL; REGL DL; EINZIG A; DUTCHER JP; WIERNIK PH; HORWITZ SB
    DEVELOPMENT OF 2 RADIOIMMUNOASSAYS TO DETECT PACLITAXEL IN SERA AND IN CEREBROSPINAL, ASCITIC, AND PLEURAL FLUIDS
    Cancer
    
    K.P. Oboyle et al., "DEVELOPMENT OF 2 RADIOIMMUNOASSAYS TO DETECT PACLITAXEL IN SERA AND IN CEREBROSPINAL, ASCITIC, AND PLEURAL FLUIDS", Cancer, 79(5), 1997, pp. 1022-1030
36. LEONARD JP; SHERMAN ML; FISHER GL; BUCHANAN LJ; LARSEN G; ATKINS MB; SOSMAN JA; DUTCHER JP; VOGELZANG NJ; RYAN JL
    EFFECTS OF SINGLE-DOSE INTERLEUKIN-12 EXPOSURE ON INTERLEUKIN-12-ASSOCIATED TOXICITY AND INTERFERON-GAMMA PRODUCTION
    Blood
    
    J.P. Leonard et al., "EFFECTS OF SINGLE-DOSE INTERLEUKIN-12 EXPOSURE ON INTERLEUKIN-12-ASSOCIATED TOXICITY AND INTERFERON-GAMMA PRODUCTION", Blood, 90(7), 1997, pp. 2541-2548
37. BHAGWATI N; DUTCHER JP; FINEBERG S; OLEKSOWICZ L
    TISSUE EXPRESSION OF A PLATELET-IMMUNORELATED GPIB RECEPTOR CORRELATES WITH BREAST MALIGNANCY AND TISSUE INVASION
    Blood
    
    N. Bhagwati et al., "TISSUE EXPRESSION OF A PLATELET-IMMUNORELATED GPIB RECEPTOR CORRELATES WITH BREAST MALIGNANCY AND TISSUE INVASION", Blood, 90(10), 1997, pp. 1330-1330
38. OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; ETKIND A
    BREAST-CARCINOMA GPIB-ALPHA-RELATED PROTEIN EXPRESSION IS REGULATED BY A PKC-SENSITIVE MECHANISM
    Blood
    
    L. Oleksowicz et al., "BREAST-CARCINOMA GPIB-ALPHA-RELATED PROTEIN EXPRESSION IS REGULATED BY A PKC-SENSITIVE MECHANISM", Blood, 90(10), 1997, pp. 1887-1887
39. SUH JG; OLEKSOWICZ L; DUTCHER JP
    LEUKOCYTOCLASTIC VASCULITIS ASSOCIATED WITH NIZATIDINE THERAPY
    The American journal of medicine
    
    J.G. Suh et al., "LEUKOCYTOCLASTIC VASCULITIS ASSOCIATED WITH NIZATIDINE THERAPY", The American journal of medicine, 102(2), 1997, pp. 216-217
40. GUCALP R; DUTCHER JP; WIERNIK PH
    OVERVIEW BY AN ONCOLOGIST - WHAT ARE THE IMAGING NEEDS OF THE ONCOLOGIST AND ONCOLOGICAL SURGEON
    Seminars in nuclear medicine
    
    R. Gucalp et al., "OVERVIEW BY AN ONCOLOGIST - WHAT ARE THE IMAGING NEEDS OF THE ONCOLOGIST AND ONCOLOGICAL SURGEON", Seminars in nuclear medicine, 27(1), 1997, pp. 3-9
41. MALIK UR; OLEKSOWICZ L; DUTCHER JP; RATECH H; BOROWITZ MJ; WIERNIK PH
    ATYPICAL CLONAL T-CELL PROLIFERATION IN INFECTIOUS-MONONUCLEOSIS
    Medical oncology
    
    U.R. Malik et al., "ATYPICAL CLONAL T-CELL PROLIFERATION IN INFECTIOUS-MONONUCLEOSIS", Medical oncology, 13(4), 1996, pp. 207-213
42. MAKOWER D; VENKATRAJ U; DUTCHER JP; WIERNIK PH
    OCCURRENCE OF MYELOMA IN A CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENT AFTERRESPONSE TO DIFFERENTIATION THERAPY WITH INTERLEUKIN-4
    Leukemia & lymphoma
    
    D. Makower et al., "OCCURRENCE OF MYELOMA IN A CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENT AFTERRESPONSE TO DIFFERENTIATION THERAPY WITH INTERLEUKIN-4", Leukemia & lymphoma, 23(5-6), 1996, pp. 617-619
43. OLEKSOWICZ L; PUSZKIN E; MROWIEC Z; ISAACS R; DUTCHER JP
    ALTERATIONS IN PLATELET-FUNCTION IN PATIENTS RECEIVING INTERLEUKIN-6 AS CYTOKINE THERAPY
    Cancer investigation
    
    L. Oleksowicz et al., "ALTERATIONS IN PLATELET-FUNCTION IN PATIENTS RECEIVING INTERLEUKIN-6 AS CYTOKINE THERAPY", Cancer investigation, 14(4), 1996, pp. 307-316
44. SPARANO JA; WIERNIK PH; HU XP; SARTA C; SCHWARTZ EL; SOEIRO R; HENRY DH; MASON B; RATECH H; DUTCHER JP
    PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA
    Journal of clinical oncology
    
    J.A. Sparano et al., "PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA", Journal of clinical oncology, 14(11), 1996, pp. 3026-3035
45. WIERNIK PH; DUTCHER JP
    SHOULD MAINTENANCE THERAPY (MT) FOR ACUTE MYELOID-LEUKEMIA (AML) BE REVISITED
    Experimental hematology
    
    P.H. Wiernik e J.P. Dutcher, "SHOULD MAINTENANCE THERAPY (MT) FOR ACUTE MYELOID-LEUKEMIA (AML) BE REVISITED", Experimental hematology, 24(9), 1996, pp. 538-538
46. SPARANO JA; LIPSITZ S; WADLER S; HANSEN R; BUSHUNOW PW; KIRKWOOD J; FLYNN PJ; DUTCHER JP; BENSON AB
    PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292
    American journal of clinical oncology
    
    J.A. Sparano et al., "PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292", American journal of clinical oncology, 19(6), 1996, pp. 546-551
47. MROWIEC ZR; OLEKSOWICZ L; ZUCKERMAN D; DELEONFERNANDEZ M; KHORSHIDI M; DUTCHER JP; PUSZKIN EG
    BUFFY COAT PLATELETS STORED IN APYRASE, APROTININ, AND ASCORBIC-ACID IN A SUSPENDED BAG - COMBINED STRATEGIES FOR REDUCING PLATELET ACTIVATION DURING STORAGE
    Transfusion
    
    Z.R. Mrowiec et al., "BUFFY COAT PLATELETS STORED IN APYRASE, APROTININ, AND ASCORBIC-ACID IN A SUSPENDED BAG - COMBINED STRATEGIES FOR REDUCING PLATELET ACTIVATION DURING STORAGE", Transfusion, 36(1), 1996, pp. 5-10
48. WIERNIK PH; DEBELLIS R; MUXI P; DUTCHER JP
    EXTRAMEDULLARY ACUTE PROMYELOCYTIC LEUKEMIA
    Cancer
    
    P.H. Wiernik et al., "EXTRAMEDULLARY ACUTE PROMYELOCYTIC LEUKEMIA", Cancer, 78(12), 1996, pp. 2510-2514
49. OLEKSOWICZ L; DUTCHER JP; DELEON M; ETKIND P
    PLATELET IMMUNORELATED GPIB-ALPHA IS EXPRESSED BY FRESH HUMAN TUMOR SPECIMENS
    Blood
    
    L. Oleksowicz et al., "PLATELET IMMUNORELATED GPIB-ALPHA IS EXPRESSED BY FRESH HUMAN TUMOR SPECIMENS", Blood, 88(10), 1996, pp. 709-709
50. OLEKSOWICZ L; DUTCHER JP
    ADHESIVE RECEPTORS EXPRESSED BY TUMOR-CELLS AND PLATELETS - NOVEL TARGETS FOR THERAPEUTIC ANTIMETASTATIC STRATEGIES
    Medical oncology
    
    L. Oleksowicz e J.P. Dutcher, "ADHESIVE RECEPTORS EXPRESSED BY TUMOR-CELLS AND PLATELETS - NOVEL TARGETS FOR THERAPEUTIC ANTIMETASTATIC STRATEGIES", Medical oncology, 12(2), 1995, pp. 95-102
51. PAIETTA E; NELSON DL; ANDERSEN J; DUTCHER JP; WIERNIK PH
    LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS ARE PREDICTIVE OF RESPONSE IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    Medical oncology
    
    E. Paietta et al., "LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS ARE PREDICTIVE OF RESPONSE IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS", Medical oncology, 12(2), 1995, pp. 121-124
52. MROWIEC ZR; OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; LALEZARI P; PUSZKIN EG
    A NOVEL TECHNIQUE FOR PREPARING IMPROVED BUFFY COAT PLATELET CONCENTRATES
    Blood cells, molecules, & diseases
    
    Z.R. Mrowiec et al., "A NOVEL TECHNIQUE FOR PREPARING IMPROVED BUFFY COAT PLATELET CONCENTRATES", Blood cells, molecules, & diseases, 21(1), 1995, pp. 25-33
53. OBOYLE KP; COLLETTI D; MAZUREK C; WANG Y; RAY SK; DIAMOND B; ROSENBLUM MG; EPSTEIN AL; SHOCHAT D; DUTCHER JP; WIERNIK PH; KLEIN RS
    POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF MONOCLONAL-ANTIBODY LYM-1 AND IMMUNOCONJUGATE LYM-1-GELONIN ON HUMAN BURKITTS-LYMPHOMA CELLS WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR
    Journal of immunotherapy with emphasis on tumor immunology
    
    K.P. Oboyle et al., "POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF MONOCLONAL-ANTIBODY LYM-1 AND IMMUNOCONJUGATE LYM-1-GELONIN ON HUMAN BURKITTS-LYMPHOMA CELLS WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR", Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 221-230
54. WEISS GR; MARGOLIN KA; SZNOL M; ATKINS MB; OLEKSOWICZ L; ISAACS R; SOSMAN JA; DOROSHOW JH; TREHU EG; DUTCHER JP; FISHER RI
    A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA
    Journal of immunotherapy with emphasis on tumor immunology
    
    G.R. Weiss et al., "A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA", Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 52-56
55. DUTCHER JP; LEONG T; MAKARY AZ; BENNETT J; FRONTIERA M; MILLER H; WIERNIK PH
    A PHASE-II STUDY OF MENOGARIL (7R-O-METHYLNOGAROL) IN PATIENTS WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP/
    Leukemia
    
    J.P. Dutcher et al., "A PHASE-II STUDY OF MENOGARIL (7R-O-METHYLNOGAROL) IN PATIENTS WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP/", Leukemia, 9(10), 1995, pp. 1638-1642
56. EINZIG AI; DUTCHER JP; WIERNIK PH
    LIFE-THREATENING HYPERLEUKOCYTOSIS AND PULMONARY COMPROMISE AFTER PRIMING WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA
    Journal of clinical oncology
    
    A.I. Einzig et al., "LIFE-THREATENING HYPERLEUKOCYTOSIS AND PULMONARY COMPROMISE AFTER PRIMING WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA", Journal of clinical oncology, 13(1), 1995, pp. 304-305
57. OLEKSOWICZ L; MROWIEC Z; ISAACS R; DUTCHER JP; PUSZKIN E
    MORPHOLOGIC AND ULTRASTRUCTURAL EVIDENCE FOR INTERLEUKIN-6 INDUCED PLATELET ACTIVATION
    American journal of hematology
    
    L. Oleksowicz et al., "MORPHOLOGIC AND ULTRASTRUCTURAL EVIDENCE FOR INTERLEUKIN-6 INDUCED PLATELET ACTIVATION", American journal of hematology, 48(2), 1995, pp. 92-99
58. KHALIL A; CIOBANU N; SPARANO JA; GUCALP R; DUTCHER JP; WIERNIK PH
    PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES
    Bone marrow transplantation
    
    A. Khalil et al., "PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES", Bone marrow transplantation, 15(1), 1995, pp. 93-97
59. OLEKSOWICZ L; MROWIEC Z; SCHWARTZ E; KHORSHIDI M; DUTCHER JP; PUSZKIN E
    CHARACTERIZATION OF TUMOR-INDUCED PLATELET-AGGREGATION - THE ROLE OF IMMUNORELATED GPIB AND GPIIB IIIA EXPRESSION BY MCF7 BREAST-CANCER CELLS/
    Thrombosis research
    
    L. Oleksowicz et al., "CHARACTERIZATION OF TUMOR-INDUCED PLATELET-AGGREGATION - THE ROLE OF IMMUNORELATED GPIB AND GPIIB IIIA EXPRESSION BY MCF7 BREAST-CANCER CELLS/", Thrombosis research, 79(3), 1995, pp. 261-274
60. MROWIEC ZR; OLEKSOWICZ L; ZUCKERMAN D; DELEONFERNANDEZ M; KHORSHIDI M; DUTCHER JP; PUSZKIN EG
    BUFFY COAT PLATELETS STORED IN PLASMA CONTAINING APYRASE, APROTININ AND ASCORBIC-ACID
    Transfusion
    
    Z.R. Mrowiec et al., "BUFFY COAT PLATELETS STORED IN PLASMA CONTAINING APYRASE, APROTININ AND ASCORBIC-ACID", Transfusion, 35(10), 1995, pp. 28-28
61. BENNETT RT; LERNER SE; TAUB HC; DUTCHER JP; FLEISCHMANN J
    CYTOREDUCTIVE SURGERY FOR STAGE-IV RENAL-CELL CARCINOMA
    The Journal of urology
    
    R.T. Bennett et al., "CYTOREDUCTIVE SURGERY FOR STAGE-IV RENAL-CELL CARCINOMA", The Journal of urology, 154(1), 1995, pp. 32-34
62. OLEKSOWICZ L; DUTCHER JP; DELEON M; ETKIND P
    GPIB-ALPHA IS EXPRESSED BY MCF-7 HUMAN BREAST-CARCINOMA CELLS
    Blood
    
    L. Oleksowicz et al., "GPIB-ALPHA IS EXPRESSED BY MCF-7 HUMAN BREAST-CARCINOMA CELLS", Blood, 86(10), 1995, pp. 327-327
63. NOVIK Y; DUTCHER JP; OLEKSOWICZ L
    INTERLEUKIN-3 AND INTERLEUKIN-11 - ABSENCE OF AN EFFECT ON IN-VITRO AGONIST-INDUCED PLATELET-AGGREGATION AND PLATELET GMP-140 EXPRESSION
    Blood
    
    Y. Novik et al., "INTERLEUKIN-3 AND INTERLEUKIN-11 - ABSENCE OF AN EFFECT ON IN-VITRO AGONIST-INDUCED PLATELET-AGGREGATION AND PLATELET GMP-140 EXPRESSION", Blood, 86(10), 1995, pp. 2792-2792
64. DUTCHER JP; LEE S; PAIETTA E; BENNETT J; STEWART J; WIERNIK PH
    AN ECOG PHASE-II STUDY OF CARBOPLATIN IN BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML-BC) (E1992)
    Blood
    
    J.P. Dutcher et al., "AN ECOG PHASE-II STUDY OF CARBOPLATIN IN BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML-BC) (E1992)", Blood, 86(10), 1995, pp. 3017-3017
65. SPARANO JA; WIERNIK PH; HU X; DUTCHER JP; SARTA C; HENRY D; MASON B
    DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)
    Blood
    
    J.A. Sparano et al., "DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)", Blood, 86(10), 1995, pp. 3724-3724
66. WIERNIK PH; SKLARIN NT; DUTCHER JP; SPARANO JA; GREENWALD ES
    ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER
    Medical oncology
    
    P.H. Wiernik et al., "ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER", Medical oncology, 11(3-4), 1994, pp. 121-125
67. GUCALP R; SPARANO J; DUTCHER JP; WIERNIK PH
    INTRODUCTION TO BONE-MARROW TRANSPLANT SYMPOSIUM HELD AT THE ALBERT-EINSTEIN-CANCER-CENTER AT BRONX, NY, USA, MARCH 23 TO 25, 1994
    Medical oncology
    
    R. Gucalp et al., "INTRODUCTION TO BONE-MARROW TRANSPLANT SYMPOSIUM HELD AT THE ALBERT-EINSTEIN-CANCER-CENTER AT BRONX, NY, USA, MARCH 23 TO 25, 1994", Medical oncology, 11(2), 1994, pp. 31-33
68. OLEKSOWICZ L; SPARANO J; OBOYLE K; VENKATRAJ U; WIERNIK PH; DUTCHER JP
    INTERLEUKINS IN CANCER-THERAPY - RATIONALE AND CURRENT STATUS
    CLINICAL IMMUNOTHERAPEUTICS
    
    L. Oleksowicz et al., "INTERLEUKINS IN CANCER-THERAPY - RATIONALE AND CURRENT STATUS", CLINICAL IMMUNOTHERAPEUTICS, 1(4), 1994, pp. 271-281
69. SPARANO JA; FISHER RI; WEISS GR; MARGOLIN K; ARONSON FR; HAWKINS MJ; ATKINS MB; DUTCHER JP; GAYNOR ER; BOLDT DH; DOROSHOW JH; ERNEST ML; SZNOL M; MIER JW
    PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS
    Journal of immunotherapy with emphasis on tumor immunology
    
    J.A. Sparano et al., "PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS", Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
70. VLOCK DR; SNYDERMAN CH; JOHNSON JT; MYERS EN; EIBLING DE; RUBIN JS; KIRKWOOD JM; DUTCHER JP; ADAMS GL
    PHASE IB TRIAL OF THE EFFECT OF PERITUMORAL AND INTRANODAL INJECTIONSOF INTERLEUKIN-2 IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OFTHE HEAD AND NECK - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL
    Journal of immunotherapy with emphasis on tumor immunology
    
    D.R. Vlock et al., "PHASE IB TRIAL OF THE EFFECT OF PERITUMORAL AND INTRANODAL INJECTIONSOF INTERLEUKIN-2 IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OFTHE HEAD AND NECK - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL", Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 134-139
71. MARGOLIN K; ARONSON FR; SZNOL M; ATKINS MB; GUCALP R; FISHER RI; SUNDERLAND M; DOROSHOW JH; ERNEST ML; MIER JW; DUTCHER JP; GAYNOR ER; WEISS GR
    PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA
    Journal of immunotherapy with emphasis on tumor immunology
    
    K. Margolin et al., "PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA", Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 147-153
72. HAWKINS MJ; ATKINS MB; DUTCHER JP; FISHER RI; WEISS GR; MARGOLIN KA; RAYNER AA; SZNOL M; PARKINSON DR; PAIETTA E; GAYNOR ER; BOLDT DH; DOROSHOW JH; ARONSON FR
    A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA
    Journal of immunotherapy with emphasis on tumor immunology
    
    M.J. Hawkins et al., "A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA", Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 74-78
73. WIERNIK PH; DUTCHER JP; LEAF AN; LIAO ZH; PAIETTA E; ROSENSTREICH DL
    OBJECTIVE RESPONSE OF MULTIPLE-MYELOMA TO CYCLOSPORINE-A
    Leukemia & lymphoma
    
    P.H. Wiernik et al., "OBJECTIVE RESPONSE OF MULTIPLE-MYELOMA TO CYCLOSPORINE-A", Leukemia & lymphoma, 16(1-2), 1994, pp. 167-170
74. DUTCHER JP; BENCHABBAT A; JONES JG; WIERNIK PH
    UNIQUE DERMATOLOGICAL COMPLICATION OF RHM-CSF TREATMENT
    Leukemia & lymphoma
    
    J.P. Dutcher et al., "UNIQUE DERMATOLOGICAL COMPLICATION OF RHM-CSF TREATMENT", Leukemia & lymphoma, 15(3-4), 1994, pp. 347-349
75. DUTCHER JP; BENCHABBAT A; JONES JG; WIERNIK PH
    UNIQUE DERMATOLOGICAL COMPLICATION OF RHM-CSF TREATMENT
    Leukemia & lymphoma
    
    J.P. Dutcher et al., "UNIQUE DERMATOLOGICAL COMPLICATION OF RHM-CSF TREATMENT", Leukemia & lymphoma, 15(3-4), 1994, pp. 347-349
76. SPARANO JA; WIERNIK PH; STRACK M; LEAF A; BECKER NH; SARTA C; CARNEY D; ELKIND R; SHAH M; VALENTINE ES; DUTCHER JP
    INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN
    Leukemia & lymphoma
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN", Leukemia & lymphoma, 14(3-4), 1994, pp. 263-271
77. MERER DM; DUTCHER JP; MERCANDO A; BRODMAN R; SUHRLAND MJ; BHANDARI A; ZIMMERMAN D; MITCHELL MS; WIERNIK PH
    CASE-REPORT - CLINICAL FINDINGS AND SUCCESSFUL RESECTION OF MELANOMA METASTATIC TO THE RIGHT ATRIUM
    Cancer investigation
    
    D.M. Merer et al., "CASE-REPORT - CLINICAL FINDINGS AND SUCCESSFUL RESECTION OF MELANOMA METASTATIC TO THE RIGHT ATRIUM", Cancer investigation, 12(4), 1994, pp. 409-413
78. WIERNIK PH; DUTCHER JP; TODD M; CALIENDO G; BENSON L
    POLYETHYLENE GLYCOLATED INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION
    American journal of hematology
    
    P.H. Wiernik et al., "POLYETHYLENE GLYCOLATED INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION", American journal of hematology, 47(1), 1994, pp. 41-44
79. OLEKSOWICZ L; ZUCKERMAN D; MROWIEC Z; PUSZKIN E; DUTCHER JP
    EFFECTS OF INTERLEUKIN-2 ADMINISTRATION ON PLATELET-FUNCTION IN CANCER-PATIENTS
    American journal of hematology
    
    L. Oleksowicz et al., "EFFECTS OF INTERLEUKIN-2 ADMINISTRATION ON PLATELET-FUNCTION IN CANCER-PATIENTS", American journal of hematology, 45(3), 1994, pp. 224-231
80. SAGAYADAN GE; WIERNIK PH; SUN N; AHEARN G; THOMPSON D; HALLAM SJ; HU XP; DUTCHER JP; GALLAGHER RE
    EFFECT OF RETINOIC ACID AND INTERFERON-ALPHA ON GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS IN CHRONIC MYELOID-LEUKEMIA - INCREASED INHIBITION BY ALL-TRANS-RETINOIC AND 13-CIS-RETINOIC ACIDS IN ADVANCED-STAGE DISEASE
    Leukemia research
    
    G.E. Sagayadan et al., "EFFECT OF RETINOIC ACID AND INTERFERON-ALPHA ON GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS IN CHRONIC MYELOID-LEUKEMIA - INCREASED INHIBITION BY ALL-TRANS-RETINOIC AND 13-CIS-RETINOIC ACIDS IN ADVANCED-STAGE DISEASE", Leukemia research, 18(10), 1994, pp. 741-748
81. OLEKSOWICZ L; STRACK M; DUTCHER JP; SUSSMAN I; CALIENDO G; SPARANO J; WIERNIK PH
    A DISTINCT COAGULOPATHY ASSOCIATED WITH INTERLEUKIN-2 THERAPY
    British Journal of Haematology
    
    L. Oleksowicz et al., "A DISTINCT COAGULOPATHY ASSOCIATED WITH INTERLEUKIN-2 THERAPY", British Journal of Haematology, 88(4), 1994, pp. 892-894
82. WALPOLE ET; DUTCHER JP; SPARANO J; GUCALP R; EINZIG A; PAIETTA E; CIOBANU N; GRIMA K; CALIENDO G; CAVASOTTO G; WIERNIK PH
    SURVIVAL AFTER PHASE-II TREATMENT OF ADVANCED RENAL-CELL CARCINOMA WITH TAXOL OR HIGH-DOSE INTERLEUKIN-2
    Journal of immunotherapy with emphasis on tumor immunology
    
    E.T. Walpole et al., "SURVIVAL AFTER PHASE-II TREATMENT OF ADVANCED RENAL-CELL CARCINOMA WITH TAXOL OR HIGH-DOSE INTERLEUKIN-2", Journal of immunotherapy with emphasis on tumor immunology, 13(4), 1993, pp. 275-281
83. DUTCHER JP
    INTERFERONS AND INTERLEUKINS IN CANCER-THERAPY
    Cancer research, therapy & control
    
    J.P. Dutcher, "INTERFERONS AND INTERLEUKINS IN CANCER-THERAPY", Cancer research, therapy & control, 3(3), 1993, pp. 181-184
84. WIERNIK PH; DUTCHER JP; PAIETTA E; GUCALP R; MARKUS S; WEINBERG V; AZAR C; GARL S; BENSON L
    LONG-TERM FOLLOW-UP OF TREATMENT AND POTENTIAL CURE OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA WITH MOAD - A NON-ANTHRACYCLINE CONTAINING REGIMEN
    Leukemia
    
    P.H. Wiernik et al., "LONG-TERM FOLLOW-UP OF TREATMENT AND POTENTIAL CURE OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA WITH MOAD - A NON-ANTHRACYCLINE CONTAINING REGIMEN", Leukemia, 7(8), 1993, pp. 1236-1241
85. SPARANO JA; WIERNIK PH; LEAF A; DUTCHER JP
    INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN RELAPSED AND RESISTANT NON-HODGKINS-LYMPHOMA - EVIDENCE FOR A SCHEDULE-DEPENDENTEFFECT FAVORING INFUSIONAL ADMINISTRATION OF CHEMOTHERAPY
    Journal of clinical oncology
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN RELAPSED AND RESISTANT NON-HODGKINS-LYMPHOMA - EVIDENCE FOR A SCHEDULE-DEPENDENTEFFECT FAVORING INFUSIONAL ADMINISTRATION OF CHEMOTHERAPY", Journal of clinical oncology, 11(6), 1993, pp. 1071-1079
86. SPARANO JA; FISHER RI; SUNDERLAND M; MARGOLIN K; ERNEST ML; SZNOL M; ATKINS MB; DUTCHER JP; MICETICH KC; WEISS GR; DOROSHOW JH; ARONSON FR; RUBINSTEIN LV; MIER JW
    RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA
    Journal of clinical oncology
    
    J.A. Sparano et al., "RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA", Journal of clinical oncology, 11(10), 1993, pp. 1969-1977
87. DUTCHER JP; WIERNIK PH; TODD M; CALIENDO G; BENSON L
    INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION
    Experimental hematology
    
    J.P. Dutcher et al., "INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION", Experimental hematology, 21(8), 1993, pp. 1048-1048
88. MAZUREK C; DUTCHER JP; SCHWARTZ EL; GARL S; BENSON L; WIERNIK PH
    PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MENOGARIL (7-CON-O-METHYLNOGAROL) IN PREVIOUSLY TREATED PATIENTS WITH ACUTE-LEUKEMIA
    Investigational new drugs
    
    C. Mazurek et al., "PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MENOGARIL (7-CON-O-METHYLNOGAROL) IN PREVIOUSLY TREATED PATIENTS WITH ACUTE-LEUKEMIA", Investigational new drugs, 11(4), 1993, pp. 313-322
89. DUTCHER JP; WIERNIK PH
    THE ROLE OF RECOMBINANT INTERLEUKIN-2 IN THERAPY FOR HEMATOLOGIC MALIGNANCIES
    Seminars in oncology
    
    J.P. Dutcher e P.H. Wiernik, "THE ROLE OF RECOMBINANT INTERLEUKIN-2 IN THERAPY FOR HEMATOLOGIC MALIGNANCIES", Seminars in oncology, 20(6), 1993, pp. 33-40
90. SPARANO JA; WADLER S; LIEBES L; ROBERT NJ; SCHWARTZ EL; DUTCHER JP
    PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER
    Cancer research
    
    J.A. Sparano et al., "PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER", Cancer research, 53(15), 1993, pp. 3509-3512
91. DUTCHER JP; LEONG T; MAKARY A; PAIETTA E; BENNETT J; CASSILETH P; WIERNIK PH
    PHASE-II STUDY OF MENOGARIL IN PATIENTS (PTS) WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) - EST 8490
    Blood
    
    J.P. Dutcher et al., "PHASE-II STUDY OF MENOGARIL IN PATIENTS (PTS) WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) - EST 8490", Blood, 82(10), 1993, pp. 10000130-10000130
92. SPARANO JA; WIERNIK PH; DUTCHER JP; LEAF A; KHALIL A
    INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) IN RELAPSED, RESISTANT, AND POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT
    Blood
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) IN RELAPSED, RESISTANT, AND POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT", Blood, 82(10), 1993, pp. 10000137-10000137
93. DUTCHER JP; WIERNIK PH; EINZIG AI; CASSILETH P
    MITOXANTRONE, VINBLASTINE AND CCNU (MVC) - A HIGHLY-ACTIVE REGIMEN INPOOR-PROGNOSIS HODGKINS-DISEASE (HD)
    Blood
    
    J.P. Dutcher et al., "MITOXANTRONE, VINBLASTINE AND CCNU (MVC) - A HIGHLY-ACTIVE REGIMEN INPOOR-PROGNOSIS HODGKINS-DISEASE (HD)", Blood, 82(10), 1993, pp. 10000143-10000143
94. SPARANO JA; WIERNIK PH; DUTCHER JP; SARTA C; STRACK M; LEAF A
    INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN
    Blood
    
    J.A. Sparano et al., "INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN", Blood, 82(10), 1993, pp. 10000386-10000386